Rwc Asset Management LLP Rhythm Pharmaceuticals, Inc. Transaction History
Rwc Asset Management LLP
- $1.74 Billion
- Q3 2025
A detailed history of Rwc Asset Management LLP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Rwc Asset Management LLP holds 1,988 shares of RYTM stock, worth $208,720. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,988Holding current value
$208,720% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
257Shares Held
64.5MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$708 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$588 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$584 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$512 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$377 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.85B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...